BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SSX1, MGC5162, 6756, ENSG00000126752, RP11-552E4_1, SSRC, MGC150425, Q16384 AND Staging
2332 results:

  • 1. Incidentally found parotid gland lesion in
    Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
    BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study.
    Lee JW; Ahn H; Yoo ID; Hong SP; Baek MJ; Kang DH; Lee SM
    Cancer Imaging; 2024 Apr; 24(1):53. PubMed ID: 38627864
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Study on mechanism of icariin-induced ferroptosis in HepG2 hepatoma carcinoma cells through PPARG/FABP4/GPX4 pathway].
    Li L; Zeng PH; Yang RY; Deng Y; He ZM; Xia X; Zhu DY; Peng QH
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1295-1309. PubMed ID: 38621977
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
    Ohama H; Hiraoka A; Tada T; Hirooka M; Kariyama K; Hatanaka T; Tani J; Takaguchi K; Atsukawa M; Itobayashi E; Nishimura T; Tsuji K; Tajiri K; Ishikawa T; Yasuda S; Toyoda H; Fukunishi S; Ogawa C; Kakizaki S; Shimada N; Naganuma A; Kawata K; Kosaka H; Kuroda H; Matono T; Yata Y; Ochi H; Tada F; Nouso K; Morishita A; Itokawa N; Okubo T; Arai T; Tsutsui A; Nagano T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2042. PubMed ID: 38577725
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and validation of nomograms to evaluate the survival outcome of HCC patients undergoing selective postoperative adjuvant TACE.
    He Y; Qian J; Zhu G; Wu Z; Cui L; Tu S; Luo L; Shan R; Liu L; Shen W; Li Y; He K
    Radiol Med; 2024 Apr; 129(4):653-664. PubMed ID: 38512609
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [A Case of Conversion Surgery for Stage Ⅳ ATP-Producing Gastric cancer with Distant Metastasis].
    Egami Y; Sugimura K; Katsuyama S; Masuzawa T; Yanagisawa K; Kinoshita M; Ikeshima R; Shinke G; Hiraki M; Ohmura Y; Hata T; Takeda Y; Murata K
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):329-331. PubMed ID: 38494821
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U
    J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
    Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
    BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Patient metabolic profile defined by liver and muscle
    Vitiello GA; Jayaprakasam VS; Tang LH; Schattner MA; Janjigian YY; Ku GY; Maron SB; Schoder H; Larson SM; Gönen M; Datta J; Coit DG; Brennan MF; Strong VE
    Gastric Cancer; 2024 May; 27(3):548-557. PubMed ID: 38436762
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study.
    Attallah KA; Albannan MS; Farid K; Rizk SM; Fathy N
    Technol Cancer Res Treat; 2024; 23():15330338241234790. PubMed ID: 38436112
    [No Abstract]    [Full Text] [Related]  

  • 11. [The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients].
    Chen C; Zhang D; Li Q; Lei JJ; Geng ZM
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):302-308. PubMed ID: 38432671
    [No Abstract]    [Full Text] [Related]  

  • 12. Integrating Navigation-Assisted Ablation in the Locoregional Treatment of Hepatocellular Carcinoma.
    Iwai Y; Agala CB; Gerber DA
    JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Split-bolus single-phase versus single-bolus split-phase CT acquisition protocols for staging in patients with testicular cancer: A retrospective study.
    O'Regan PW; Dewhurst C; O'Mahony AT; O'Regan C; O'Leary V; O'Connor G; Ryan D; Maher MM; Young R
    Radiography (Lond); 2024 Mar; 30(2):628-633. PubMed ID: 38330895
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study.
    Bektaş M; Işık EG; Oğuz E; Kemik F; Abbasgholizadeh A; İnce B; Özkan ZG; Yalçınkaya Y; Artım-Esen B; Gül A; İnanç M
    Clin Exp Rheumatol; 2024 Feb; 42(2):358-366. PubMed ID: 38293968
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.
    Wang Y; Sun X; Chen C; Ge H; Sun J; Li E; Cai Z; Fu Q; Sun X; Wu J; Ye M; Cao W; Chen Q; Wei X; Han X; Sun K; Yan Q; Huang W; Wu L; Zeng Y; Zhang Q; Liang T
    Cancer Lett; 2024 Mar; 585():216654. PubMed ID: 38272344
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
    Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
    Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
    Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
    [No Abstract]    [Full Text] [Related]  

  • 18. Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma.
    Du XJ; Wang GY; Zhu XD; Han YQ; Lei F; Shen LF; Yang KY; Chen L; Mao YP; Tang LL; Li L; Wu Z; Xu GQ; Zhou Q; Huang J; Guo R; Zhang Y; Liu X; Zhou GQ; Li WF; Xu C; Lin L; Chen YP; Chen FP; Liang XY; Chen SY; Li SQ; Cui CY; Li JB; Ren J; Chen MY; Liu LZ; Sun Y; Ma J
    Cancer Cell; 2024 Mar; 42(3):464-473.e3. PubMed ID: 38242125
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic yield of contrast-enhanced abdominal staging CT in patients with initially diagnosed breast cancer.
    Jeong B; Lee YW; Lee SB; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Gwark S; Shin HJ; Yoo TK; Choi SH
    Eur J Radiol; 2024 Feb; 171():111295. PubMed ID: 38241854
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Study on the comparison of postoperative liver injury caused by hepatic arterial perfusion chemotherapy combined with targeted immunotherapy with hepatic arterial chemoembolization combined with targeted immunotherapy for intermediate-and advanced-stage liver cancer].
    Li R; Li WL; Yuan GS; Pang HJ; Li Q; Hu XY; Guo YB; Chen JZ; Zang MY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1163-1168. PubMed ID: 38238949
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 117.